4.8 Review

Lytic cell death in metabolic liver disease

Journal

JOURNAL OF HEPATOLOGY
Volume 73, Issue 2, Pages 394-408

Publisher

ELSEVIER
DOI: 10.1016/j.jhep.2020.04.001

Keywords

Programmed cell death; Necroptosis; Pyroptosis; Ferroptosis; NAFLD; NASH; ASH; Hemochromatosis; Niemann-Pick disease; Gaucher's disease

Funding

  1. Mairie de Paris (Emergences)
  2. Societe Francophone du Diabete (SFD)
  3. Institute of Cardiometabolism and Nutrition (ICAN)
  4. Fondation pour la Recherche Medicale (FRM) [ARF20170938613]
  5. NIH [DK 124182]
  6. Digestive Disease Research Center for Cell Signaling in Gastroenterology [P30DK084567]
  7. Chris M Carlos and Catharine Nicole Jockisch Carlos Foundation for PSC
  8. Mayo Clinic
  9. Fundacao para a Ciencia e a Tecnologia (FCT)
  10. European Structural & Investment Funds through the COMPETE Programme [UID/DTP/04138/2019, PTDC/MED-FAR/29097/2017, SAICTPAC/0019/2015 -LISBOA-01-0145-FEDER-016405]
  11. EU H2020 Marie Sklodowska-Curie Project Foie Gras [722619]
  12. Fundação para a Ciência e a Tecnologia [PTDC/MED-FAR/29097/2017] Funding Source: FCT

Ask authors/readers for more resources

Regulated cell death is intrinsically associated with inflammatory liver disease and is pivotal in governing outcomes of metabolic liver disease. Different types of cell death may coexist as metabolic liver disease progresses to inflammation, fibrosis, and ultimately cirrhosis. In addition to apoptosis, lytic forms of hepatocellular death, such as necroptosis, pyroptosis and ferroptosis elicit strong inflammatory responses due to cell membrane permeabilisation and release of cellular components, contributing to the recruitment of immune cells and activation of hepatic stellate cells. The control of liver cell death is of fundamental importance and presents novel opportunities for potential therapeutic intervention. This review summarises the underlying mechanism of distinct lytic cell death modes and their commonalities, discusses their relevance to metabolic liver diseases of different aetiologies, and acknowledges the limitations of current knowledge in the field. We focus on the role of hepatocyte necroptosis, pyroptosis and ferroptosis in non-alcoholic fatty liver disease, alcohol-associated liver disease and other metabolic liver disorders, as well as potential therapeutic implications. (c) 2020 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available